Form 4 for PCVX Vaxcyte, Inc.
Accepted 2023-06-15 00:00:00 ET · period of report 2023-06-13 · accession 0001209191-23-037505 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-15 | 2023-06-13 | PCVX | Loxam Teri | Dir | A - Grant | $0.00 | +2,500 | 5,625 | +80% | $0 |
| D | 2023-06-15 | 2023-06-13 | PCVX | Loxam Teri | Dir | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-13 | A | A | 2,500 | $0.00 | 5,625 | D | — | — | (F1) Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date. |
| 2 | Derivative | Stock Option (right to buy) | 2023-06-13 | A | A | 15,000 | $0.00 | 15,000 | D | $53.08 · — to 2033-06-12 | 15,000 Common Stock | (F2) The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date. |